BETA

4 Amendments of Patrizia TOIA related to 2016/2057(INI)

Amendment 13 #
Draft opinion
Paragraph 1 a (new)
1a. Recalls that is the fundamental right of each individual to enjoy the best possible state of health;
2016/09/09
Committee: DEVE
Amendment 62 #
Draft opinion
Paragraph 4 a (new)
4a. Underlines the key role played by public investments in R&D and highlight the importance of implementing measures to ensure a public health return on investments when EU funds are financing medical R&D, including the provision of conditions attached to public R&D funding that ensure biomedical research results in suitable and affordable medicines;
2016/09/09
Committee: DEVE
Amendment 64 #
Draft opinion
Paragraph 4 a (new)
4a. Underlines the need for greater transparency and more information on how EU funds are invested in the development of new drugs;
2016/09/09
Committee: DEVE
Amendment 77 #
Draft opinion
Paragraph 5 a (new)
5a. Considering that tuberculosis has become the world's leading infectious killer and that the most dangerous form of the disease is the multi-drug resistant one, underlines the importance of tackling the emerging antimicrobial resistance crisis, including funding research and development for new tools for vaccines, diagnostics and treatment for tuberculosis, while ensuring sustainable and affordable access for those new tools to make sure no one is left behind;
2016/09/09
Committee: DEVE